Reaktionsgleichung
[CH2:1]([O:4][C:5]1[CH:10]=[CH:9][C:8]([S:11]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)(=[O:13])=[O:12])=[CH:7][C:6]=1[C:20]1[NH:29][C:28](=[O:30])[C:27]2[C:22](=[C:23](Br)[CH:24]=[CH:25][CH:26]=2)[N:21]=1)[CH2:2][CH3:3].[CH2:32]=[CH:33][CH2:34][CH2:35][CH2:36][CH2:37][CH3:38]>>[CH2:1]([O:4][C:5]1[CH:10]=[CH:9][C:8]([S:11]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)(=[O:13])=[O:12])=[CH:7][C:6]=1[C:20]1[NH:29][C:28](=[O:30])[C:27]2[C:22](=[C:23]([CH:32]=[CH:33][CH2:34][CH2:35][CH2:36][CH2:37][CH3:38])[CH:24]=[CH:25][CH:26]=2)[N:21]=1)[CH2:2][CH3:3]Komponenten
3
Versuchsvorschrift
The title compound is prepared analogously to the method of Example 1, starting with 2-(2-n-propoxy-5-morpholinosulfonylphenyl)-8-bromoquinazolin-4(3H)-one and 1-heptene.
Quellen und Nachweise
- ORD-Eintrag
- ord-36f6c2358b8b4e43b2e3adab177400ea
- Quelldatensatz
- uspto-grants-2001_02
- Patentnummer
- US06187779B1
Verknüpfte Notizen
Wird geladen…